Über uns
Im Jahr 2021 feiert die bioactiva diagnostica GmbH ihr 20-jähriges Bestehen. In der Firmengeschichte unseres Unternehmens gab es einige Schlüsselmomente, die uns dahin geführt haben, wo wir heute stehen. Diese Momente haben dazu beigetragen, unsere Kernwerte zu entwickeln und das nachhaltige Wachstum und den Erfolg unseres Unternehmens zu sichern.
Mehr erfahren
The definition of tuberculosis infection based on the spectrum of tuberculosis disease
Latent tuberculosis infection was the term traditionally used to indicate tuberculosis (TB) infection. This term was used to define “a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens through tests such as the tuberculin skin test (TST) or an interferon-γ release assay (IGRA) without clinically active TB”.
Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy
As an ancient infectious disease, tuberculosis (TB) is still the leading cause of death from a single infectious agent worldwide. Latent TB infection (LTBI) has been recognized as the largest source of new TB cases and is one of the biggest obstacles to achieving the aim of the End TB Strategy.
LIOFeron®TB/LTBI: A novel and reliable test for LTBI and tuberculosis
High accuracy diagnostic screening tests for tuberculosis (TB) are required to improve the diagnosis of both active TB and latent Mycobacterium tuberculosis (MTB) infection (LTBI). The novel IGRA LIOFeron®TB/LTBI assay was tested and its accuracy was compared to the QuantiFERON®-TB Gold Plus assay.
Arab Health 2023
Internationales Kongress- und Ausstellungszentrum Dubai | 30 Januar -02 February 2023
Unsere Partner
